list of digital currency Knowledge

Jingmen, the Yiwei Lithium Energy Super Energy Storage Factory, was put into operation, with the largest production capacity in Central China. Following the opening and operation of Jingjing High-speed Railway, on December 10th, the Yiwei Lithium Energy 60GWh Super Energy Storage Factory project was officially put into operation in the new energy and new materials industrial park of Duodao District, Jingmen High-tech Zone, becoming a lithium battery production base with the largest production capacity and the longest industrial chain in Central China. The total investment of this project is 10.8 billion yuan, and the first phase covers an area of about 700 mu. It mainly produces MB56 large iron-lithium energy storage batteries, and its cell capacity and cycle times are 25% and 20% higher than those of the same industry products respectively, which are widely used in electric energy storage, ship energy storage and other fields. Taking an electric ship as an example, the voyage distance can be increased by about 40% by using MB56 battery, and the battery life can be extended by about two years.3 Lianban Huifa Food: Zhenghechang Investment reduced its shareholding by 1 million shares today, and the reduction plan has not yet been completed. On November 8, 2024, the company disclosed the Announcement on Shareholder Reduction Plan of Huifa Food, and the shareholder Zhenghechang Investment Co., Ltd. plans to reduce its shareholding by centralized bidding, not exceeding 2,446,400 shares, not exceeding 1% of the company's total share capital; The reduction of holdings through block trading shall not exceed 4,892,800 shares, and shall not exceed 2% of the company's total share capital. The planned reduction period is from November 29, 2024 to February 27, 2025. On December 11th, 2024, Zhenghechang Investment Co., Ltd. reduced its shareholding by 1 million shares through centralized bidding. At present, the shareholder's shareholding reduction plan has not been completed.The Ministry of Finance successfully issued the sixth issue of RMB 6 billion treasury bonds in 2024 in Hong Kong. On December 11th, the Ministry of Finance of People's Republic of China (PRC) issued the sixth issue of RMB 6 billion treasury bonds in 2024 in Hong Kong Special Administrative Region for institutional investors, which was widely welcomed by investors, with a subscription multiple of 3.58 times. Among them, the two-year (additional issuance) is 2 billion yuan, and the issue price is 100.62 yuan, corresponding to the issue interest rate of 1.70%; 3-year (additional issuance) 2 billion yuan, the issue price is 101.28 yuan, corresponding to the issue interest rate of 1.70%; 5-year (additional issuance) 2 billion yuan, the issue price is 102.41 yuan, corresponding to the issue interest rate of 1.80%.

Market news: Poland will promote common defense funds during its presidency of the European Union.Kremlin: Actions in the Golan Heights and the buffer zone are unlikely to help stabilize the situation in Syria.The Shanghai Stock Exchange approved the refinancing of Dizhe Medicine to support the development of new quality productivity. The announcement of Dizhe Medicine shows that the private placement plan of Dizhe Medicine in science and technology innovation board has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of unprofitable enterprises in Shanghai Stock Exchange has been approved since the issuance of the Eight Measures on Deepening science and technology innovation board's Reform, Service, Scientific and Technological Innovation and Development of New Productivity by CSRC. As a listed company with the fifth standard in science and technology innovation board, Dizhe Medicine's refinancing has been approved by Shanghai Stock Exchange, which reflects the institutional inclusiveness and support of the capital market for supporting new quality productivity and unprofitable technology-based enterprises with key core technologies, great market potential and outstanding scientific and technological attributes. Dizhe Medicine said that the company's refinancing will help the company to further accelerate product research and development and production base construction, create new quality productivity, implement major national strategies, promote products to the sea, and give scientific and technological impetus to the development of biomedical economy. (Sina Technology)

Albertson terminated its merger with krogh and announced an increase in dividend and repurchase plan. albertson Company announced that it had exercised its right to terminate its merger agreement with krogh, because the US District Court in Oregon and the District Court in Washington issued an injunction on the proposed merger on December 10th. Vivek Sankaran, CEO of the company, commented: "In view of the recent decision of the federal and state courts to block the proposed merger between the company and krogh, we have made a difficult decision to terminate the merger agreement. We are very disappointed with the court's decision. " In addition, the board of directors of albertson Company plans to increase the quarterly cash dividend from $0.12 to $0.15 per share, and approved a stock repurchase plan of up to $2 billion.German Foreign Ministry Spokesperson: Berlin will hold the Weimar Triangle Foreign Ministers' Meeting on Thursday, and representatives from Italy, Spain, Britain and the European Union will also attend.Diplomat: The EU envoy failed to reach an agreement on the 15th round of sanctions against Russia.